A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
Clinical trial NCT05970432 · UNKNOWN
Trial details
- NCT number
- NCT05970432
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2024-03-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.